LaMontagne M P, Markovac A, Menke J R
J Med Chem. 1977 Sep;20(9):1123-7. doi: 10.1021/jm00219a003.
Primaquine (I) has been extensively used in combination with other drugs in the radical cure of relapsing malaria as well as for prophylaxis or the interruption of transmission. This, coupled with the activity data reported for 4-methylprimaquine (II), has led to the synthesis of a series of 14 4-substituted analogues of I. In addition, three side-chain analogues of II were prepared. The compounds were tested for suppressive antimalarial activity against Plasmodium berghei in the Rane mouse screen and for radical curative activity against Plasmodium cynomolgi in the rhesus monkey. Four of the 17 compounds prepared (1a, 9c, 15, and 17) exhibited activity in at least one of the test systems.
伯氨喹(I)已被广泛与其他药物联合用于间日疟的根治,以及预防或阻断传播。这一点,再加上所报道的4-甲基伯氨喹(II)的活性数据,促使人们合成了一系列I的14种4-取代类似物。此外,还制备了II的三种侧链类似物。这些化合物在Rane小鼠模型中针对伯氏疟原虫进行了抑制性抗疟活性测试,并在恒河猴中针对食蟹猴疟原虫进行了根治活性测试。所制备的17种化合物中的4种(1a、9c、15和17)在至少一种测试系统中表现出活性。